The new INM Neuroproteomics platform aims at using the latest technological developments in mass spectrometry for the discovery and investigation of the role of peptides, proteins and their post-translationnal modifications (PTMs) in fundamental and translationnal research in Neuroscience. The Neuroproteomics Plateform is connected with the CHU Clinical Proteomics Platform (https://ppc-montpellier.com/), also scientifically led by Pr C Hirtz and operationally by Dr Jérôme Vialaret (CHU).

 

Contact

Hirtz Christophe